Login / Signup

Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients.

Brian P EplingJohn H Powers
Published in: Antimicrobial agents and chemotherapy (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors